325 related articles for article (PubMed ID: 7522240)
1. A comparison of postspace-flight orthostatic intolerance to vasovagal syncope and autonomic failure and the potential use of the alpha agonist midodrine for these conditions.
Piwinski SE; Jankovic J; McElligott MA
J Clin Pharmacol; 1994 May; 34(5):466-71. PubMed ID: 7522240
[TBL] [Abstract][Full Text] [Related]
2. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine).
Kaufmann H; Brannan T; Krakoff L; Yahr MD; Mandeli J
Neurology; 1988 Jun; 38(6):951-6. PubMed ID: 2452997
[TBL] [Abstract][Full Text] [Related]
3. Midodrine prescribed to improve recurrent post-spaceflight orthostatic hypotension.
Platts SH; Ziegler MG; Waters WW; Mitchell BM; Meck JV
Aviat Space Environ Med; 2004 Jun; 75(6):554-6. PubMed ID: 15198285
[TBL] [Abstract][Full Text] [Related]
4. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.
Jankovic J; Gilden JL; Hiner BC; Kaufmann H; Brown DC; Coghlan CH; Rubin M; Fouad-Tarazi FM
Am J Med; 1993 Jul; 95(1):38-48. PubMed ID: 7687093
[TBL] [Abstract][Full Text] [Related]
5. Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders.
McTavish D; Goa KL
Drugs; 1989 Nov; 38(5):757-77. PubMed ID: 2480881
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.
Ramirez CE; Okamoto LE; Arnold AC; Gamboa A; Diedrich A; Choi L; Raj SR; Robertson D; Biaggioni I; Shibao CA
Hypertension; 2014 Dec; 64(6):1235-40. PubMed ID: 25185131
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
Kuritzky L; Espay AJ; Gelblum J; Payne R; Dietrich E
Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
[TBL] [Abstract][Full Text] [Related]
8. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.
Fouad-Tarazi FM; Okabe M; Goren H
Am J Med; 1995 Dec; 99(6):604-10. PubMed ID: 7503082
[TBL] [Abstract][Full Text] [Related]
9. Drug treatment of orthostatic hypotension because of autonomic failure or neurocardiogenic syncope.
Lamarre-Cliche M
Am J Cardiovasc Drugs; 2002; 2(1):23-35. PubMed ID: 14727996
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study.
Lamarre-Cliche M; Souich Pd; Champlain Jd; Larochelle P
Clin Ther; 2008 Sep; 30(9):1629-38. PubMed ID: 18840368
[TBL] [Abstract][Full Text] [Related]
11. Drug treatment of orthostatic hypotension and vasovagal syncope.
Frishman WH; Azer V; Sica D
Heart Dis; 2003; 5(1):49-64. PubMed ID: 12549988
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of midodrine after spaceflight in astronauts without orthostatic hypotension.
Platts SH; Ziegler MG; Waters WW; Meck JV
Aviat Space Environ Med; 2006 Apr; 77(4):429-33. PubMed ID: 16676655
[TBL] [Abstract][Full Text] [Related]
13. Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, double-blind, placebo-controlled, randomized, tilt-table study.
Smith W; Wan H; Much D; Robinson AG; Martin P
Clin Auton Res; 2016 Aug; 26(4):269-77. PubMed ID: 27372462
[TBL] [Abstract][Full Text] [Related]
14. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study.
Kaufmann H; Saadia D; Voustianiouk A
Ann Neurol; 2002 Sep; 52(3):342-5. PubMed ID: 12205647
[TBL] [Abstract][Full Text] [Related]
15. Midodrine in neurogenic orthostatic hypotension. A new treatment.
Gilden JL
Int Angiol; 1993 Jun; 12(2):125-31. PubMed ID: 7690383
[TBL] [Abstract][Full Text] [Related]
16. Midodrine for orthostatic hypotension and recurrent reflex syncope: A systematic review.
Izcovich A; González Malla C; Manzotti M; Catalano HN; Guyatt G
Neurology; 2014 Sep; 83(13):1170-7. PubMed ID: 25150287
[TBL] [Abstract][Full Text] [Related]
17. Midodrine: a selective alpha-adrenergic agonist for orthostatic hypotension and dialysis hypotension.
Cruz DN
Expert Opin Pharmacother; 2000 May; 1(4):835-40. PubMed ID: 11249519
[TBL] [Abstract][Full Text] [Related]
18. Midodrine prevents orthostatic intolerance associated with simulated spaceflight.
Ramsdell CD; Mullen TJ; Sundby GH; Rostoft S; Sheynberg N; Aljuri N; Maa M; Mukkamala R; Sherman D; Toska K; Yelle J; Bloomfield D; Williams GH; Cohen RJ
J Appl Physiol (1985); 2001 Jun; 90(6):2245-8. PubMed ID: 11356789
[TBL] [Abstract][Full Text] [Related]
19. Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.
Schirger A; Sheps SG; Thomas JE; Fealey RD
Mayo Clin Proc; 1981 Jul; 56(7):429-33. PubMed ID: 6166817
[TBL] [Abstract][Full Text] [Related]
20. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension.
McClellan KJ; Wiseman LR; Wilde MI
Drugs Aging; 1998 Jan; 12(1):76-86. PubMed ID: 9467688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
